Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target - British Journal of Anaesthesia
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Opioids in cancer: The κ‑opioid receptor (Review)
RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
Untangling the complexity of opioid receptor function | Neuropsychopharmacology